Hi Ruby, I share your positive outlook for the company and Dr G....

Hi Ruby,
I share your positive outlook for the company and Dr G.
The HKSE listing is forecast in Jan-Mar 19, from the ASX ANN on 8 Aug.
The NASDAQ listing is forecast in Jan-Feb 19, from the ASX ANN on 2 Oct.
So it’s not clear to me which will be first.
Irrespective, there will need to be some ‘big ticket items’ in the upcoming announcements to prime potential new investors, including CFDA for Prizma, contracts (not just MOUs) for distribution of Prizma and Patch, revenue from IDTFs, etc.
It’s helpful to remember that Dr G will need to get the revenue ramping up quickly to $30M by 8 May 19 to get his substantial performance shares.
My guess is that he’ll do everything possible to keep his holding above 50%, so with the NASDAQ listing he’ll need these performance shares to do this. In the meantime, if the company needs more cash, he’ll just increase his loan.